The National Diabetes Audit (NDA) is a major national clinical audit, which measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales.
The NDA is delivered byNHS Digital, in partnership with Diabetes UK. It collects and analyses data and produces reports for a range of stakeholders to use to drive changes and improve the quality of services and health outcomes for people with diabetes.
The NDA includes four distinct areas of diabetes care, treatment and outcome. Further information can be found on the NHS Digital website, using the links below:
- National Diabetes Core Audit (NDA): This annual audit of primary care and specialist diabetes services covers care processes, treatment targets, complications and mortality.
- National Diabetes Inpatient Audit (NaDIA):This is a snapshot audit of every hospital covering inpatient care of people with diabetes.
- National Pregnancy in Diabetes (NPID) Audit:This audit examines antenatal services for women with pre-gestational diabetes.
- National Diabetes Footcare Audit (NDFA):This audit collects data about specialist foot care services for people with diabetes.
- National Diabetes Transtion Audit (NDTA): This joint initiative links the NDA and National Paediatric Diabetes Audit (NPDA) datasets to measure if young people experience a smooth transition of care from paediatric diabetes services to adult diabetes services.
The Royal College of Paediatrics and Child Health (RCPCH) manages the paediatric component of the NDA. For more information, please go tothe RCPCH website.
For more information about the NDA, or to be kept informed of ongoing developments, please email@example.com.